Home/Filings/4/0001104659-20-065897
4//SEC Filing

Stephan Dietrich A 4

Accession 0001104659-20-065897

CIK 0001173281other

Filed

May 25, 8:00 PM ET

Accepted

May 26, 4:39 PM ET

Size

7.5 KB

Accession

0001104659-20-065897

Insider Transaction Report

Form 4
Period: 2020-05-21
Stephan Dietrich A
DirectorPresident and CEO10% Owner
Transactions
  • Purchase

    Common Stock

    2020-05-21$8.09/sh+1,250$10,11111,250 total
Holdings
  • Common Stock

    (indirect: See footnote)
    2,547,639
Transactions
  • Purchase

    Common Stock

    2020-05-21$8.09/sh+1,250$10,11111,250 total
Holdings
  • Common Stock

    (indirect: See footnote)
    2,547,639
Footnotes (2)
  • [F1]Shares held by Dietrich Stephan as a tenant by the entirety with his spouse.
  • [F2]Shares held directly by Lipizzaner LLC, of which Dr. Stephan is the sole member.

Issuer

NeuBase Therapeutics, Inc.

CIK 0001173281

Entity typeother

Related Parties

1
  • filerCIK 0001774588

Filing Metadata

Form type
4
Filed
May 25, 8:00 PM ET
Accepted
May 26, 4:39 PM ET
Size
7.5 KB